产品名称 | NebuSelect™ Recombinant Cynomolgus IL-23 alpha&IL-12 beta, His-tag |
---|---|
目录号 | NBL-240903 |
别名 | IL-23 alpha&IL-12 beta |
外观 | see COA |
分子量 | Val22-Pro189(IL-23 alpha) & Pro23-Leu328(IL-12 beta) |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | A0A2K5TLV4-1(IL-23 alpha)&XP_045250400.1(IL-12 beta) |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-240903-100ug | 100ug | Inquire | Inquire | |
NBL-240903-1mg | 1mg | Inquire | Inquire | |
NBL-240903-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Cynomolgus IL-23 alpha&IL-12 beta, His-tag
Catalog#:
NBL-240903
Description:
NebuSelect™ Recombinant Cynomolgus IL-23 alpha&IL-12 beta, His-tag(Cat#NBL-240903) is expressed in HEK293 with His tag at the N-terminus.It contains Val22-Pro189(IL-23 alpha) & Pro23-Leu328(IL-12 beta).
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 19.52 kDa (IL-23 alpha) and 34.76 kDa (IL-12 beta). Due to glycosylation, the protein migrates to 20-25 kDa (IL-23 alpha) and 40-50 kDa (IL-12 beta) based on Bis-Tris PAGE result.
Target Name:
IL-23 alpha&IL-12 beta
Target Information:
The interleukin (IL)-12 family of cytokines, including IL12 and IL 23, play an important role in driving aberrant Th1 and Th17 immune responses in patients with Crohn's disease (CD). Targeting this pathway has opened new avenues for therapeutic intervention. The balance of proinflammatory cytokines interleukin (IL)-12 and IL-23 plays a key role in shaping the development of antitumor or protumor immunity.
Amino Acid Sequence:
Val22-Pro189(IL-23 alpha) & Pro23-Leu328(IL-12 beta)
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.